The store will not work correctly when cookies are disabled.
1-Ethyl-5-(3-phenyl-allylidene)-2-thioxo-dihydropyrimidine-4,6-dione
ID: ALA4167289
PubChem CID: 71509637
Max Phase: Preclinical
Molecular Formula: C15H14N2O2S
Molecular Weight: 286.36
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCN1C(=O)/C(=C\C=C\c2ccccc2)C(=O)NC1=S
Standard InChI: InChI=1S/C15H14N2O2S/c1-2-17-14(19)12(13(18)16-15(17)20)10-6-9-11-7-4-3-5-8-11/h3-10H,2H2,1H3,(H,16,18,20)/b9-6+,12-10-
Standard InChI Key: FYLVAJBJNHSEIY-QJUYYABZSA-N
Molfile:
RDKit 2D
20 21 0 0 0 0 0 0 0 0999 V2000
10.3798 -10.7241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3798 -9.9091 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.0875 -9.4974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7994 -9.9091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7994 -10.7241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0875 -11.1357 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.0875 -8.6783 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.5072 -11.1357 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.6720 -11.1357 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
12.5072 -9.4974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2150 -9.9091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9227 -9.4974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6346 -9.9091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3424 -9.4974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0502 -9.9091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0502 -10.7241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3424 -11.1357 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6346 -10.7241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0875 -11.9548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3798 -12.3623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
1 6 1 0
3 7 2 0
5 8 2 0
1 9 2 0
10 11 1 0
11 12 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
13 18 2 0
12 13 1 0
4 10 2 0
19 20 1 0
6 19 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 286.36 | Molecular Weight (Monoisotopic): 286.0776 | AlogP: 1.89 | #Rotatable Bonds: 3 |
Polar Surface Area: 49.41 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 7.70 | CX Basic pKa: ┄ | CX LogP: 2.78 | CX LogD: 2.61 |
Aromatic Rings: 1 | Heavy Atoms: 20 | QED Weighted: 0.52 | Np Likeness Score: -0.98 |
References
1. Ramisetti SR, Pandey MK, Lee SY, Karelia D, Narayan S, Amin S, Sharma AK.. (2018) Design and synthesis of novel thiobarbituric acid derivatives targeting both wild-type and BRAF-mutated melanoma cells., 143 [PMID:29133035] [10.1016/j.ejmech.2017.11.006] |